Summary by Moomoo AI
Doximity reported strong fiscal Q2 2025 results with revenue reaching $136.8 million, up 20% YoY, while net income grew 44% to $44.2 million. The company achieved an adjusted EBITDA of $76.1 million, representing a 41% YoY increase and margins of 55.7%. Operating cash flow surged 430% to $68.3 million.The company's clinical workflow tools saw record usage with over 600,000 unique active prescribers. Looking ahead, Doximity provided Q3 guidance with expected revenue between $152-153 million and adjusted EBITDA of $83-84 million. For fiscal year 2025, the company updated its guidance to revenue of $535-540 million and adjusted EBITDA of $274-279 million.As the leading digital platform for U.S. medical professionals, Doximity's network includes more than 80% of U.S. physicians across all specialties. The company continues to focus on helping doctors improve productivity and provide better patient care through its digital tools and collaboration platform.
